Viewing Study NCT00020202


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-31 @ 9:08 AM
Study NCT ID: NCT00020202
Status: COMPLETED
Last Update Posted: 2024-03-04
First Post: 2007-03-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive Stage Small Cell Lung Cancer View
None Stage IIIA Non-small Cell Lung Cancer View
None Stage IV Non-small Cell Lung Cancer View
None Recurrent Small Cell Lung Cancer View
None Stage IIIB Non-small Cell Lung Cancer View
None Recurrent Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult solid tumor View
None body system/site cancer View
None cancer View
None extensive stage small cell lung cancer View
None genetic condition View
None lung cancer View
None non-small cell lung cancer View
None recurrent non-small cell lung cancer View
None recurrent small cell lung cancer View
None small cell lung cancer View
None solid tumor View
None stage III non-small cell lung cancer View
None stage IIIA non-small cell lung cancer View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None stage, non-small cell lung cancer View
None stage, small cell lung cancer View
None thorax/respiratory cancer View